1B38
     RDKit          3D

 10 11  0  0  0  0  0  0  0  0999 V2000
    1.4530   31.0030    6.6910 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1200   29.8590    6.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780   28.6720    6.9310 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9630   28.6570    7.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2000   29.7400    8.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4350   30.9830    7.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1950   32.1280    7.7750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7080   29.3770    9.0570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5280   28.1410    9.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4810   27.5940    8.5420 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 10  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
  8  9  2  0
  9 10  1  0
M  END
>  <pdb_header>  (1) 
HEADER    TRANSFERASE                             17-DEC-98   XXXX
TITLE     HUMAN CYCLIN-DEPENDENT KINASE 2
COMPND    CELL DIVISION PROTEIN KINASE 2
KEYWDS    PROTEIN KINASE, TRANSFERASE, SERINE/THREONINE PROTEIN
KEYWDS   2 KINASE, ATP-BINDING, CELL CYCLE, CELL DIVISION, MITOSIS,
KEYWDS   3 PHOSPHORYLATION
EXPDTA    X-RAY DIFFRACTION
AUTHOR    N.R.BROWN, M.E.M.NOBLE, A.M.LAWRIE, M.C.MORRIS, P.TUNNAH,
AUTHOR   2 G.DIVITA, L.N.JOHNSON, J.A.ENDICOTT
JRNL        AUTH   N.R.BROWN, M.E.NOBLE, A.M.LAWRIE, M.C.MORRIS,
JRNL        AUTH 2 P.TUNNAH, G.DIVITA, L.N.JOHNSON, J.A.ENDICOTT
JRNL        TITL   EFFECTS OF PHOSPHORYLATION OF THREONINE 160 ON
JRNL        TITL 2 CYCLIN-DEPENDENT KINASE 2 STRUCTURE AND ACTIVITY.
JRNL        REF    J.BIOL.CHEM.                  V. 274  8746 1999
JRNL        REFN   ASTM JBCHA3  US ISSN 0021-9258
JRNL        PMID   10085115
JRNL        DOI    10.1074/JBC.274.13.8746
REMARK   1
REMARK   1 REFERENCE 1
REMARK   1  AUTH   U.SCHULZE-GAHMEN, J.BRANDSEN, H.D.JONES,
REMARK   1  AUTH 2 D.O.MORGAN, L.MEIJER, J.VESELY, S.H.KIM
REMARK   1  TITL   MULTIPLE MODES OF LIGAND RECOGNITION: CRYSTAL
REMARK   1  TITL 2 STRUCTURES OF CYCLIN-DEPENDENT PROTEIN KINASE 2 IN
REMARK   1  TITL 3 COMPLEX WITH ATP AND TWO INHIBITORS, OLOMOUCINE
REMARK   1  TITL 4 AND ISOPENTENYLADENINE
REMARK   1  REF    PROTEINS                      V.  22   378 1995
REMARK   1  REFN   ASTM PSFGEY  US ISSN 0887-3585
SEQRES   1 A  299  ACE MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU
SEQRES   2 A  299  GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU
SEQRES   3 A  299  THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP
SEQRES   4 A  299  THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU
SEQRES   5 A  299  ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL
SEQRES   6 A  299  LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR
SEQRES   7 A  299  LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE
SEQRES   8 A  299  MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU
SEQRES   9 A  299  ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA
SEQRES  10 A  299  PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS
SEQRES  11 A  299  PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS
SEQRES  12 A  299  LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO
SEQRES  13 A  299  VAL ARG THR TYR THR HIS GLU VAL VAL THR LEU TRP TYR
SEQRES  14 A  299  ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER
SEQRES  15 A  299  THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA
SEQRES  16 A  299  GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER
SEQRES  17 A  299  GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY
SEQRES  18 A  299  THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET
SEQRES  19 A  299  PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN
SEQRES  20 A  299  ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY
SEQRES  21 A  299  ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN
SEQRES  22 A  299  LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE
SEQRES  23 A  299  PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU
HETNAM     ACE ACETYL GROUP
HETNAM      MG MAGNESIUM ION
HETNAM     ATP ADENOSINE-5'-TRIPHOSPHATE
FORMUL   1  ACE    C2 H4 O
FORMUL   2   MG    MG 2+
FORMUL   3  ATP    C10 H16 N5 O13 P3
FORMUL   4  HOH   *206(H2 O)
HELIX    1   1 SER A   46  GLU A   57  1                                  12
HELIX    2   2 LEU A   87  ALA A   93  1                                   7
HELIX    3   3 LEU A  101  SER A  120  1                                  20
HELIX    4   4 PRO A  130  ASN A  132  5                                   3
HELIX    5   5 LEU A  148  PHE A  152  1                                   5
HELIX    6   6 PRO A  171  LEU A  174  1                                   4
HELIX    7   7 THR A  182  THR A  198  5                                  17
HELIX    8   8 GLU A  208  LEU A  219  1                                  12
HELIX    9   9 VAL A  230  SER A  232  5                                   3
HELIX   10  10 PHE A  248  VAL A  251  1                                   4
HELIX   11  11 GLU A  257  MET A  266  1                                  10
HELIX   12  12 ALA A  277  ALA A  282  1                                   6
HELIX   13  13 PRO A  284  PHE A  286  5                                   3
SHEET    1   A 5 LEU A  66  THR A  72  0
SHEET    2   A 5 LYS A  75  GLU A  81 -1  N  VAL A  79   O  LEU A  67
SHEET    3   A 5 VAL A  29  ILE A  35 -1  N  ILE A  35   O  LEU A  76
SHEET    4   A 5 VAL A  17  ASN A  23 -1  N  ALA A  21   O  VAL A  30
SHEET    5   A 5 PHE A   4  LYS A   9 -1  N  GLU A   8   O  LYS A  20
SHEET    1   B 2 LEU A 133  ILE A 135  0
SHEET    2   B 2 ILE A 141  LEU A 143 -1  N  LYS A 142   O  LEU A 134
LINK         C   ACE A   0                 N   MET A   1     1555   1555  1.33
LINK        MG    MG A 382                 OD1 ASN A 132     1555   1555  2.12
LINK        MG    MG A 382                 OD2 ASP A 145     1555   1555  2.02
LINK        MG    MG A 382                 O2G ATP A 381     1555   1555  2.16
LINK        MG    MG A 382                 O2A ATP A 381     1555   1555  2.12
LINK        MG    MG A 382                 O   HOH A 412     1555   1555  2.09
LINK        MG    MG A 382                 O1B ATP A 381     1555   1555  2.13
SITE     1 AC1  4 ASN A 132  ASP A 145  ATP A 381  HOH A 412
SITE     1 AC2 25 ILE A  10  GLU A  12  GLY A  13  THR A  14
SITE     2 AC2 25 GLY A  16  VAL A  18  ALA A  31  LYS A  33
SITE     3 AC2 25 VAL A  64  PHE A  80  GLU A  81  PHE A  82
SITE     4 AC2 25 LEU A  83  ASP A  86  ASP A 127  LYS A 129
SITE     5 AC2 25 GLN A 131  ASN A 132  LEU A 134  ASP A 145
SITE     6 AC2 25  MG A 382  HOH A 412  HOH A 414  HOH A 580
SITE     7 AC2 25 HOH A 585
CRYST1   53.333   71.122   72.190  90.00  90.00  90.00 P 21 21 21    4
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.018750  0.000000  0.000000        0.00000
SCALE2      0.000000  0.014060  0.000000        0.00000
SCALE3      0.000000  0.000000  0.013852        0.00000

$$$$
